Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Consuming asthma medicines during pregnancy may raise the risk of premature births and small birth weight

Staff Writer
Staff Writer 3 years ago
Updated 2021/10/23 at 2:11 PM
Share
SHARE

Consuming asthma medication during pregnancy may increase the risk of premature births and small birth weight, a recent study released in PLOS One has found.

For the study, the data containing prescriptions of all births after 24 gestational weeks within the Wales region of England was analyzed. The data was collected between early-2000 and late-2010.

In totality, the study involved more than 38,000 infants born between that timespan and numerous more maternal prescriptions for asthma medicines.

From the findings: “Prescription of asthma medicines before or during pregnancy was associated with higher prevalence of adverse perinatal outcomes, particularly if prescriptions were discontinued during pregnancy.”

The findings also conclude, “Women discontinuing medicines during pregnancy could be identified from prescription records. The impact of targeting close monitoring and breastfeeding support warrants exploration.”

The study was authored by Gareth Davies, Sue Jordan, Daniel Thayer, David Tucker, and Ioan Humphreys.

Photo: Kayla Papazian

You Might Also Like

Study boasts MDMA-assisted therapy for PTSD patients

How the brain is organized is revealed by the largest genetic study of brain structure to date

Study investigates the ethical implications of combining the analysis of ancient DNA and data from private genetic databases

New study reveals positive results from postpartum depression treatment Zuranolone

New study explores magic mushrooms for anorexia nervosa psychopathology

TAGGED: maternal health, asthma, pediatrics
Staff Writer December 9, 2020
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article The psychedelic ibogaine may be useful for psychiatric disorders, including addiction
Next Article The intensity of Facebook use correlated with trust in the social platform

Recommended

Clinical

Study boasts MDMA-assisted therapy for PTSD patients

1 Min Read
Clinical

How the brain is organized is revealed by the largest genetic study of brain structure to date

2 Min Read
Clinical

Study investigates the ethical implications of combining the analysis of ancient DNA and data from private genetic databases

3 Min Read
Clinical

New study reveals positive results from postpartum depression treatment Zuranolone

2 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?